Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 9 11 2019
medline: 3 11 2021
entrez: 9 11 2019
Statut: ppublish

Résumé

Exercise performance is known to predict outcome in hypertrophic cardiomyopathy (HCM), but whether sex-related differences exist is unresolved. We explored whether functional impairment, assessed by exercise echocardiography, has comparable predictive accuracy in females and males with HCM. We retrospectively evaluated 292 HCM patients (46 ± 16 years, 72% males), consecutively referred for exercise echocardiography; 242 were followed for 5.9 ± 4.2 years. Peak exercise capacity was 6.5 ± 1.6 metabolic equivalents (METs). Sixty patients (21%) showed impaired exercise capacity (≤5 METs). Exercise performance was reduced in females, compared with males (5.6 ± 1.6 vs 6.9 ± 1.5 METs, Female patients with HCM showed significant age-related impairment in functional capacity compared with males, particularly evident in post-menopausal age groups. While women were at greater risk of HCM-related complications and death, impaired exercise capacity predicted adverse outcome only in men. These findings suggest the need for sex-specific management strategies in HCM.

Identifiants

pubmed: 31698967
doi: 10.1177/2047487319886961
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1821-1831

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Luca Ghiselli (L)

Division of Cardiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Department of Medicine, Section of Cardiology, University of Verona, Verona, Italy.
Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.

Alberto Marchi (A)

Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.

Carlo Fumagalli (C)

Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.

Niccolò Maurizi (N)

Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.

Andrea Oddo (A)

Cardiology Department, Careggi University Hospital, Florence, Italy.

Francesco Pieri (F)

Cardiology Department, Careggi University Hospital, Florence, Italy.

Francesca Girolami (F)

Department of Pediatric Cardiology, Meyer Children's Hospital, Florence, Italy.

Ethan Rowin (E)

Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, MA, USA.

Francesco Mazzarotto (F)

Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
Cardiovascular Research Centre, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

Mariantonietta Cicoira (M)

Department of Medicine, Section of Cardiology, University of Verona, Verona, Italy.

Flavio Ribichini (F)

Department of Medicine, Section of Cardiology, University of Verona, Verona, Italy.

Anna Arretini (A)

Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.

Mattia Targetti (M)

Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.

Silvia Passantino (S)

Department of Pediatric Cardiology, Meyer Children's Hospital, Florence, Italy.

Franco Cecchi (F)

Department of Cardiology, San Luca Hospital, Istituto Auxologico Italiano, Milano, Italy.

Niccolò Marchionni (N)

Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.

Martin Maron (M)

Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, MA, USA.

Fabio Mori (F)

Cardiology Department, Careggi University Hospital, Florence, Italy.

Iacopo Olivotto (I)

Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH